Goldman Sachs Maintains Buy on Aptiv, Lowers Price Target to $71

Benzinga Newsdesk www.benzinga.com Neutral 59.0%

Neg 0% Neu 59% Pos 0%

Goldman Sachs analyst Mark Delaney maintains Aptiv (NYSE:APTV) with a Buy and lowers the price target from $82 to $71.

Comments

No comments yet. Be the first!